Rationale and Design of the Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering (MIRACL) Study That Evaluates Atorvastatin in Unstable Angina Pectoris and in Non–Q-Wave Acute Myocardial Infarction

This publication has 16 references indexed in Scilit:

• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• Methodology of serial ECG classification using an adaptation of the NOVACODE for Q wave myocardial infarction in the bypass angioplasty revascularization investigation (BARI)
  Journal of Electrocardiology, 1996
• A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes
  New England Journal of Medicine, 1996
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S)
  The Lancet, 1995
• Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.
  Circulation, 1994
• Prospective comparision of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapy
  Journal of the American College of Cardiology, 1993
• Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease
  The Lancet, 1990
• Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
  Journal of the American Society of Echocardiography, 1989
• The Electrocardiogram in Population Studies
  Circulation, 1960